Harnessing Blockchain Technology For Better Pharma Functions
The pharmaceutical sector happens to be significant for enhancing and sustaining public health. It is responsible when it comes to exploring, developing, producing, as...
FDA Draft Guidance Supports Decentralized Clinical Trials
US Food and Drug Administration has come up with a novel draft guidance in order to further support the use of decentralised clinical trials...
Pharma Industry Groups Criticise Proposed EU Drug Regulation
The EU's drug regulations can get a major makeover soon. In a set of proposals, the European Commission looks to address numerous shortfalls troubling...
EU States Seek Reduced Reliance On Chinese Pharma Imports
A group involving 19 European Union member countries is pushing for steps to lessen the bloc’s dependence when it comes to Chinese imports as...
Phase I Trial of The South Korean DuoChol Vaccine In Sweden
The South Korea-based International Vaccine Institute- IVI has gone ahead with the clinical manufacturing of DuoChol, a new low-cost oral vaccine for cholera in...
EU Drug Manufacturing Law Changes Disappoint Manufacturers
The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws. The changes have...
AMR Is The Main Focus of New Research Consortium In World
Global research consortium is being set up to address the international impact of antimicrobial resistance (AMR). Significantly, the Centres for Antimicrobial Optimisation Network- CAMO-Net...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...





















